AUA 2017: Panel Discussion: Advances in Imaging in Urologic Oncology
Boston, MA (UroToday.com) Dr. Damien Bolton presented on PSMA-PET CT and the importance in urologic oncology. He described PSMA-PET as being useful in restaging for a biochemical recurrence and primary staging in high risk disease. He discussed the meta-analysis his group performed for patients for those who had biochemical recurrence the sensitivity and specificity were 86%.
AUA 2017: Big Renal Angiomyolipoma: The 4 cm size limit for conservative management should be revisited?
Boston, MA (UroToday.com) Recent publications have challenged the previous dogma that is unsafe to follow AML > 4 cm in size. Previous reports stated the risk of bleeding rose proportionally with AML size and the likelihood of a successful nephron-sparing procedure was less likely in larger masses.
AUA 2017: Quantitative Digital Image Analysis and Machine Learning Accurately Classifies Primary Prostate Tumors of Bone Metastatic Disease Based on Histomorphometric Features in Diagnostic Prostate Needle Biopsies
Boston, MA (UroToday.com) Biomarker development in prostate cancer (PC) is the subject of intensive research. Investigators from UCLA presented a novel and extraordinarily powerful platform that uses digital imaging analysis to classify tissue characteristics in ways that were previously unfathomable.
AUA 2017: Polyurethanes for Urinary Stents: A Study on Materials’ Stone Encrustation Performances
Boston, MA (UroToday.com) Encrustation has been a serious issue regarding materials used to build indwelling stents and catheters for urologic use. Currently there are multiple medically available material options for stents and catheters, which include: polycarbonate polyurethane (PU), silicone, polyether PU, and polyester PU. The goal of Li and colleges was to determine the levels of encrustation of each material against the ‘gold standard’ silicon.
AUA 2017: Randomized Clinical Trial of Treatment With Tamsulosin Begun In The Emergency Department To Promote Passage Of Urinary Stones
Boston, MA (UroToday.com) Urinary stone disease is very common affecting 1 in 11 people over a life time with a prevalence that doubled past 15 years. Patient visits to the ED have increased over the past few years. Alpha blockers have been used for stone expulsion.
AUA 2017: Plenary: Next Frontier: State-of-the-Art Lecture: Epidemiological Studies in Stone Disease
Boston, MA (UroToday.com) Dr. Gary Curhan, MD from the Department of Nephrology at Harvard Medical School provided an up-to-date epidemiological summary of the state of renal stone disease in the United States. Dr. Curhan performed an analysis of the current literature as it relates to risk factors in nephrolithiasis and gave his own recommendations for patient care and counseling for renal stone recurrence. The primary aim was to discuss risk factors as they relate to recurrent nephrolithiasis (5% reported in adults) rather than primary prevention of renal stone disease.
AUA 2017: A prospective randomized study evaluating safety and efficacy of bilateral simultaneous retrograde intrarenal surgery for endoscopic management of bilateral renal calculi
Boston, MA (UroToday.com) Patients with bilateral urolithiasis are often counseled on staged retrograde intrarenal surgery (RIRS) versus bilateral RIRS in the same setting. Urologists often prefer to perform a staged procedure given the perceived morbidity associated with bilateral surgery.